Great strides have been achieved in the development of quality-of-care measures and standards for inflammatory bowel disease (IBD) over the last decade. The central structural component of care in IBD revolves around the multidisciplinary team, which should be equipped with the necessary resources to operate and implement decisions. Process measures have been defined by interest groups and can be adapted into process tools for the delivery of care for various patient subgroups and clinical scenarios. The emerging treat-to-target approach to IBD management may be used to achieve optimal long-term and holistic patient-centred outcomes, such as survival, control of inflammation and disease progression, symptomatic remission, quality of life and complications. Other important quality-of-care outcome measures for IBD include disutility of care, healthcare utilization and other patient-reported outcomes such as nutritional status and impact of fistulae. The current challenge for healthcare providers and health systems is the integration of quality-of-care structures and processes into clinical practice, and the consistent delivery of updated evidence-based quality IBD care to various patient populations by individual health care providers. Finally, the awareness and appreciation for quality of care in IBD is increasing in Asia, and Asian healthcare institutions should be encouraged to take the lead in improving the quality of care in IBD.
Citations
Citations to this article as recorded by
Improving access to inflammatory bowel disease care in Canada: The patient experience Shehzeen Lalani, Holly Mathias, Courtney Heisler, Noelle Rohatinsky, Raza M Mirza, Olga Kits, Sandra Zelinsky, Geoffrey Nguyen, Peter L Lakatos, Sharyle Fowler, Kevin Rioux, Jennifer L Jones Journal of Health Services Research & Policy.2025; 30(1): 12. CrossRef
Identification and prioritization of patient-centred strategies to enhance IBD-related care for older adults: a modified Delphi approach Noelle Rohatinsky, Natasha Tooke, Sharyle Fowler, Christian Rueda-Clausen, Dirk Morrison, Judith Winchester, Juan-Nicolás Peña-Sánchez Journal of the Canadian Association of Gastroenterology.2024; 7(5): 384. CrossRef
Person-Centered Coordinated Care Experience of People With Long-Term Conditions in the Balearic Islands Measured by the P3CEQ Gabriel Mercadal-Orfila, Salvador Herrera-Pérez, Núria Piqué, Francesc Mateu-Amengual, Pedro Ventayol-Bosch, Maria Antonia Maestre-Fullana, Joaquin Ignacio Serrano-López de las Hazas, Francisco Fernández-Cortés, Francesc Barceló- Sansó, Santiago Rios Health Services Insights.2024;[Epub] CrossRef
Empowering inflammatory bowel disease patients with at-home remote disease and therapeutic drug monitoring Graham Johnson Gastrointestinal Nursing.2024; 22(7): 337. CrossRef
Holistic healthcare in inflammatory bowel disease: time for patient-centric approaches? Padhmanand Sudhakar, Judith Wellens, Bram Verstockt, Marc Ferrante, João Sabino, Séverine Vermeire Gut.2023; 72(1): 192. CrossRef
The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission Johan Burisch, Mirabella Zhao, Selwyn Odes, Peter De Cruz, Severine Vermeire, Charles N Bernstein, Gilaad G Kaplan, Dana Duricova, Dan Greenberg, Hans O Melberg, Mamoru Watanabe, Hyeong Sik Ahn, Laura Targownik, Valérie E H Pittet, Vito Annese, KT Park, K The Lancet Gastroenterology & Hepatology.2023; 8(5): 458. CrossRef
The 2023 Impact of Inflammatory Bowel Disease in Canada: Access to and Models of Care Holly Mathias, Noelle Rohatinsky, Sanjay K Murthy, Kerri Novak, M Ellen Kuenzig, Geoffrey C Nguyen, Sharyle Fowler, Eric I Benchimol, Stephanie Coward, Gilaad G Kaplan, Joseph W Windsor, Charles N Bernstein, Laura E Targownik, Juan-Nicolás Peña-Sánchez, K Journal of the Canadian Association of Gastroenterology.2023; 6(Supplement): S111. CrossRef
Der IBD-Control-Fragebogen: Deutsche Übertragung und Validierung des standardisierten Fragebogens zur Messung des Outcomes aus Patientensicht bei chronisch entzündlichen Darmerkrankungen
Annabell Müller, Selina Simone Bilger, Andreas Göldi, Gunther Meinlschmidt, Florian Rueter, Alexander Kappes, Petr Hruz, Christoph Andreas Meier, Jan Hendrik Niess Zeitschrift für Gastroenterologie.2022; 60(06): 911. CrossRef
High Risk of Fractures Within 7 Years of Diagnosis in Asian Patients With Inflammatory Bowel Diseases Hyung Jin Ahn, Ye-Jee Kim, Ho-Su Lee, Jin Hwa Park, Sung Wook Hwang, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Beom-Jun Kim, Sang Hyoung Park Clinical Gastroenterology and Hepatology.2022; 20(5): e1022. CrossRef
Appendiceal Orifice Inflammation Is Associated with Lower Rate of Complete Endoscopic Remission in Patients with Ulcerative Colitis Chang Kyo Oh, Han Hee Lee, Jin Su Kim, Bo-In Lee, Young-Seok Cho Journal of Personalized Medicine.2022; 12(5): 748. CrossRef
Risk of Hepatitis B Virus (HBV) Reactivation in Patients with Immune-Mediated Inflammatory Diseases Receiving Biologics: Focus on the Timing of Biologics after Anti-HBV Treatment Soo Min Ahn, Jonggi Choi, Byong Duk Ye, Suk-Kyun Yang, Ji Seon Oh, Yong‑Gil Kim, Chang-Keun Lee, Bin Yoo, Sang Hyoung Park, Seokchan Hong Gut and Liver.2022; 16(4): 567. CrossRef
Clinical Remission and Psychological Management are Major Issues for the Quality of Life in Pediatric Crohn Disease Anne Gourdonneau, Léa Bruneau, Frank M. Ruemmele, Lorenzo Norsa, Armelle Takeda, Catherine Le Gall, Haude Clouzeau, Laurent Rebouissoux, Alain Dabadie, Laure Bridoux‐Henno, Julie Rebeuh, Nadège Thomassin, Jérôme Viala, Stéphanie Willot, Anne Breton, Stéph Journal of Pediatric Gastroenterology and Nutrition.2021; 72(1): 74. CrossRef
Trends in hospitalizations and mortality for inflammatory bowel disease from a nationwide database study between 2008 and 2018 Asim Kichloo, Zain El-amir, Dushyant Singh Dahiya, Farah Wani, Hafeez Shaka Baylor University Medical Center Proceedings.2021; 34(5): 550. CrossRef
Classification According to Subjectivity of Inflammatory Bowel Disease Patients Using Q Methodology Jun Lee The Korean Journal of Gastroenterology.2021; 78(1): 1. CrossRef
Subjective Needs and Thoughts for the Treatment of Patients with Inflammatory Bowel Disease: Applying Q Methodology Yong Eun Park, Jin Lee, Jongha Park, Joon Hyuk Choi, Nae Yun Heo, Seung Ha Park, Yoon Kyoung Lee, Tae Oh Kim The Korean Journal of Gastroenterology.2021; 78(1): 37. CrossRef
Improving the care of inflammatory bowel disease (IBD) patients: perspectives and strategies for IBD center management Jihye Park, Sinyoung Park, Shin Ae Lee, Soo Jung Park, Jae Hee Cheon The Korean Journal of Internal Medicine.2021; 36(5): 1040. CrossRef
Risk and characteristics of tuberculosis after anti-tumor necrosis factor therapy for inflammatory bowel disease: a hospital-based cohort study from Korea Jae Yong Lee, Kyunghwan Oh, Hee Seung Hong, Kyuwon Kim, Seung Wook Hong, Jin Hwa Park, Sung Wook Hwang, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Ho-Su Lee, Kyung-Wook Jo, Sang Hyoung Park BMC Gastroenterology.2021;[Epub] CrossRef
Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases Soo-Kyung Park, Chang Hwan Choi, Jaeyoung Chun, Heeyoung Lee, Eun Sun Kim, Jae Jun Park, Chan Hyuk Park, Bo-In Lee, Yunho Jung, Dong-Il Park, Do Young Kim, Hana Park, Yoon Tae Jeen Intestinal Research.2020; 18(1): 18. CrossRef
Nationwide improvement in outcomes of emergency admission for ulcerative colitis in England, 2005‐2013 Mustafa Shawihdi, Susanna Dodd, Constantinos Kallis, Pete Dixon, Ruth Grainger, Stuart Bloom, Fraser Cummings, Mike Pearson, Keith Bodger Alimentary Pharmacology & Therapeutics.2019; 50(2): 176. CrossRef